- Home
- MAMA vs CMPS Comparison
MAMA vs CMPS Comparison
Compare MAMA & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- CMPS
- Stock Information
- Founded
- MAMA 2010
- CMPS 2020
- Country
- MAMA United States
- CMPS United Kingdom
- Employees
- MAMA N/A
- CMPS N/A
- Industry
- MAMA Specialty Foods
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- CMPS Health Care
- Exchange
- MAMA Nasdaq
- CMPS Nasdaq
- Market Cap
- MAMA 290.7M
- CMPS 280.2M
- IPO Year
- MAMA N/A
- CMPS 2020
- Fundamental
- Price
- MAMA $9.17
- CMPS $4.67
- Analyst Decision
- MAMA Strong Buy
- CMPS Strong Buy
- Analyst Count
- MAMA 4
- CMPS 7
- Target Price
- MAMA $10.00
- CMPS $30.67
- AVG Volume (30 Days)
- MAMA 267.1K
- CMPS 950.7K
- Earning Date
- MAMA 12-10-2024
- CMPS 10-31-2024
- Dividend Yield
- MAMA N/A
- CMPS N/A
- EPS Growth
- MAMA N/A
- CMPS N/A
- EPS
- MAMA 0.13
- CMPS N/A
- Revenue
- MAMA $113,593,000.00
- CMPS N/A
- Revenue This Year
- MAMA $18.91
- CMPS N/A
- Revenue Next Year
- MAMA $12.69
- CMPS N/A
- P/E Ratio
- MAMA $70.20
- CMPS N/A
- Revenue Growth
- MAMA 17.81
- CMPS N/A
- 52 Week Low
- MAMA $3.46
- CMPS $4.00
- 52 Week High
- MAMA $9.98
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- MAMA 57.15
- CMPS 46.00
- Support Level
- MAMA $7.65
- CMPS $4.00
- Resistance Level
- MAMA $9.98
- CMPS $4.66
- Average True Range (ATR)
- MAMA 0.45
- CMPS 0.29
- MACD
- MAMA 0.05
- CMPS 0.03
- Stochastic Oscillator
- MAMA 65.24
- CMPS 57.76
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.